Quest Diagnostics (DGX) revenue

Revenue · fiscal 2025
$11.04B

Quest Diagnostics (DGX) reported revenue of $11.04B in fiscal 2025 (the year ended December 31, 2025). That is 11.8% higher than the $9.87B of fiscal 2024. Figures as of 18 Nov 2026, 11:44 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Revenue, fiscal 2025
$11.04B
Change on fiscal 2024
+11.8%
Growth, 5 years
+3.2% a year
Growth, 10 years
+3.9% a year
Highest on record
$11.04Bfiscal 2025
Lowest on record
$6.70Bfiscal 2007
Fiscal years on record
192007–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Quest Diagnostics revenue, in more detail

Over the five fiscal years to 2025 revenue grew at a compound 3.2% a year; over ten years the rate was 3.9% a year. Across the 19 fiscal years on record (2007–2025), the highest was $11.04B in fiscal 2025 and the lowest $6.70B in fiscal 2007.

History · 19 fiscal years

Revenue by fiscal year

Quest Diagnostics revenue, year by year

Quest Diagnostics (DGX) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2025$11.04B 11.8% up
2024$9.87B 6.7% up
2023$9.25B 6.4% down
2022$9.88B 8.4% down
2021$10.79B 14.3% up
2020$9.44B 22.1% up
2019$7.73B 2.6% up
2018$7.53B 1.7% up
2017$7.40B 2.6% up
2016$7.21B 3.7% down
2015$7.49B 0.8% up
2014$7.44B 4.0% up
2013$7.15B 3.2% down
2012$7.38B 0.1% down
2011$7.39B 1.8% up
2010$7.26B 2.6% down
2009$7.46B 2.8% up
2008$7.25B 8.1% up
2007$6.70B—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

Revenue at health care companies of similar size

Revenue of Quest Diagnostics and comparable companies
CompanyRevenueFiscal year
Labcorp Holdings LH$13.95B2025
DexCom DXCM$4.66B2025
Koninklijke Philips PHG€17.83B2025
Roivant Sciences ROIV$8.26M2026
West Pharmaceutical Services WST$3.07B2025
Quest Diagnostics DGX$11.04B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on DGX

Quest Diagnostics, figure by figure

Quest Diagnostics (DGX) overview: price, valuation and scorecardAll health care companies by market value

Quest Diagnostics revenue: questions and answers

What is Quest Diagnostics's revenue?

Quest Diagnostics (DGX) reported revenue of $11.04B in fiscal 2025 (the year ended December 31, 2025). That is 11.8% higher than the $9.87B of fiscal 2024.

What is the growth rate of Quest Diagnostics's revenue?

Over the five fiscal years to 2025 revenue grew at a compound 3.2% a year; over ten years the rate was 3.9% a year.

What are the highest and lowest revenue figures on record for Quest Diagnostics?

Across the 19 fiscal years on record (2007–2025), the highest was $11.04B in fiscal 2025 and the lowest $6.70B in fiscal 2007.

How is Quest Diagnostics's revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement. For Quest Diagnostics it is on record here for 19 fiscal years, 2007 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Quest Diagnostics (DGX) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/DGX/revenue

Underlying data: the company's filings with the SEC and Yahoo Finance.